Bangladesh vs Côte d'Ivoire: Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Côte d'Ivoire
100.0%
in 2024
Bangladesh rank
1st
Côte d'Ivoire rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Côte d'Ivoire
How they compare
Bangladesh currently reports 100.0% against 100.0% in Côte d'Ivoire, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2010 it was Côte d'Ivoire ahead.
Bangladesh ranks 1st and Côte d'Ivoire ranks 1st of 180 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.1% | 60.3% | 10.2% | Côte d'Ivoire |
| 2020s | 96.0% | 98.4% | 2.4% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Côte d'Ivoire?
- Bangladesh, at 100.0% against 100.0% in Côte d'Ivoire as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Côte d'Ivoire?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Côte d'Ivoire?
- 14 years are reported by both, from 2010 to 2024.
- How do Bangladesh and Côte d'Ivoire rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Côte d'Ivoire ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.